Join Meeting Now

Your data is secure and never shared.

Oman
November 2026

Oman Medical Footwear Market Size, Share & Forecast, By Product Type and Distribution Channel, 2025-2032

2032

The Oman Medical Footwear Market is worth USD 10 million in 2025 and is projected to reach USD 17 million by 2032 at a CAGR of 8.68% (2025-2032). MuscatMed, Al Farsi Medical Supplies, Noon, Modern Care Medical Equipment Center and Avicen Pharmacy are the major companies operating in this market.

Report Details

Base Year

2025

Pages

86

Region

Oman

Author

Ken Research

Product Code
KR-RPT-V02-16760

CHAPTER 1 - MARKET SUMMARY

Market Overview

The Oman Medical Footwear Market links clinical referrals with retail and institutional purchasing. An estimated 412,300 adults aged 20-79 in Oman lived with diabetes in 2024. Within that population, assessed foot risk, prior ulceration, and footwear fit determine who may need therapeutic footwear. Suppliers therefore compete for access to clinicians and buyers who can identify the appropriate product and support follow-up.

Muscat is the main distribution hub. Medical supply retailers accounted for an estimated 35% of national sales in 2025, and a Muscat specialist offers foot-pressure assessment alongside footwear. Concentrating samples and fitting capacity in the capital can help suppliers cover more referrals with the same stock. Replenishing partner outlets outside Muscat can extend that reach without duplicating a full size range at every location.

Market Value

USD 10 million

Oman, 2025

Dominant Region

Muscat Governorate

2025

Dominant Segment

Diabetic Footwear

2025

Total Number of Players

60

Oman, 2025 estimate

Future Outlook

Oman’s market is projected to rise from USD 10 million in 2025 to USD 17 million in 2032, a value CAGR of 8.68% (2025-2032) following 7.23% (2020-2025). The base case assumes that more assessed patients complete a fitting, retailers replenish core sizes more frequently, and the product mix shifts toward extra-depth and custom-fitted footwear. Diabetes-related risk supports the demand pool, while referrals and affordability determine how much of that pool becomes paid demand. A supplier can monitor that conversion through completed fittings per referral, time to dispense, and the share of patients who return for replacements.

Volume is projected to reach 252,000 pair-equivalents in 2032 as specialist distribution widens and remote ordering makes it easier to replace a previously fitted model. First-time purchases and cases needing an individualized fit are more likely to use a clinic or specialist retailer. The forecast assumes selective adoption of premium products and incremental channel expansion. It treats broader reimbursement as an upside scenario. Oman's Dhamani platform provides a mechanism for exchanging health insurance transactions, while the benefit schedule for each policy determines what a buyer can claim.

8.68%

Forecast CAGR

USD 17 Mn

2032 Projection

Base Year

2025

Historical Period

2020-2025

Forecast Period

2025-2032

Historical CAGR

7.23% (2020-2025)

CHAPTER 2 - SCOPE OF REPORT

Scope of the Market

CHAPTER 3 - Key Stakeholders

Key Target Audience

Key stakeholders can use the market analysis for investment, strategy, and operational planning.

Investors

Gross margins, inventory turns, cash conversion, expansion economics

Corporates

Referral conversion, size coverage, price realization, channel economics

Government

Screening reach, geographic access, product compliance, procurement continuity

Operators

Fitting throughput, size fill rates, returns, replenishment lead times

Financial institutions

Working capital, stock aging, order concentration, cash collection

What You'll Gain

  • Market sizing and trajectory
  • Product and channel taxonomy
  • Peer country benchmarks
  • Import exposure indicators
  • Competitive player profiles
  • Fitting and pricing priorities

80+

Pages of insights

CHAPTER 4 - Market Size & Growth

Market Size, Growth Forecast and Trends

This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers. Market sizes are displayed to the nearest USD million. Growth and selling-price calculations use underlying model values, retained in the market-size cells.

Historical & Projected Market Size ($ Million)

Year-over-Year Growth Rate (%)

Market Value vs Volume Growth (%)

Historical Market Performance (2020-2025)

Modeled volume increased by 40,000 pair-equivalents over the historical period, a volume CAGR of 6.40% (2020-2025). The backcast places the trough in 2020 and the peak in 2025. Volume growth rose from 4.55% in 2021 to 7.38% in 2023 as the model assumes more clinic-led fitting and retail access after early-period disruption. The resulting trajectory is consistent with a category that relied on imported stock and physical fitting for new patients. The broad footwear import series provides historical context, while category-specific sales and the year-to-year recovery path remain modeled.

Forecast Market Outlook (2025-2032)

Market value reaches USD 17 million in 2032, a CAGR of 8.68% (2025-2032). Volume grows at 7.69% (2025-2032), while the implied average selling price rises from USD 63.33 in 2025 to USD 67.50 in 2032. The difference reflects a modest shift toward extra-depth and fitted products. Value growth peaks at 9.09% in 2030 within the supplied projection and settles near 8.7% annually in the final two years. Inventory planning should separate routine size replenishment from made-to-measure orders, where fitting time and cash tied up in work in progress affect profitability.

CHAPTER 5 - Market Data

Market Breakdown

The increase in unit demand supports a broader size range. Selling-price and product-mix projections help management assess whether the added stock and fitting capacity can earn their cost.

Market Breakdown

Historical Data (2020-2024) • Base Data (2025) • Forecast Data (2026-2032)

Year
Market Size (USD Mn)
YoY Growth (%)
Volume (Pair-Equivalents)
Implied ASP (USD per Pair-Equivalent)
Diabetic Footwear Revenue Mix (%)
Period
2020$7 Mn+Series opening year110,00060.91
$#%
Forecast
2021$7 Mn+5.97%115,00061.74
$#%
Forecast
2022$8 Mn+7.04%122,00062.30
$#%
Forecast
2023$8 Mn+7.89%131,00062.60
$#%
Forecast
2024$9 Mn+7.32%140,00062.86
$#%
Forecast
2025$10 Mn+7.95%150,00063.33
$#%
Forecast
2026$10 Mn+8.42%161,50063.78
$#%
Forecast
2027$11 Mn+8.74%173,90064.40
$#%
Forecast
2028$12 Mn+8.93%187,30065.14
$#%
Forecast
2029$13 Mn+8.20%201,70065.44
$#%
Forecast
2030$14 Mn+9.09%217,20066.30
$#%
Forecast
2031$16 Mn+8.68%234,00066.88
$#%
Forecast
2032$17 Mn+8.69%252,00067.50
$#%
Forecast

Volume

reached an estimated 150,000 pair-equivalents in Oman in 2025. Avicen lists 43 pharmacy branches in Oman, illustrating how a chain can distribute core cast-shoe sizes and share replenishment stock across outlets.

Implied ASP

was USD 63.33 per pair-equivalent in Oman in 2025. The public medical-supplies directorate publishes a dedicated orthotic price list for 2023, making institutional pricing a separate benchmark when evaluating the margins available through tenders and specialist retail.

Diabetic Footwear Revenue Mix

reaches a modeled 49.0% in Oman in 2032. About half of Oman’s adult diabetes cases were estimated to be undiagnosed in 2024, so fitting capacity has the strongest near-term commercial case where clinics already reach diagnosed patients.

CHAPTER 6 - Segmentation

Market Segmentation Framework

Seven dimensions describe what buyers purchase, where they obtain it, and which clinical and commercial requirements shape the sale.

No of Segments

7

Dominant Segment

Product Type

Fastest Growing Segment

Distribution Channel

Product Type

Diabetic Footwear
$%
Orthopedic Footwear
$%
Post-Surgical Footwear
$%
Therapeutic Comfort Footwear
$%

Distribution Channel

Medical Supply Retail
$%
Pharmacy Retail
$%
Cross-Border E-Commerce
$%
Clinical Dispensing
$%

Application

Diabetic Foot Risk Management
$%
Musculoskeletal Support
$%
Postoperative Recovery
$%

Customer Type

Households
$%
Private Healthcare Buyers
$%
Public Healthcare Buyers
$%

Fit Configuration

Stock Fit
$%
Modified Stock Fit
$%
Made-to-Measure Fit
$%

Price Tier

Entry Tier
$%
Mid-Tier
$%
Premium Tier
$%

Geography

Muscat
$%
Al Batinah
$%
Dhofar
$%
Other Governorates
$%

Key Segmentation Takeaways

The product and channel dimensions explain different decisions. Product choice determines fitting and inventory requirements, while channel choice determines how the buyer obtains the product.

Product Type

Diabetic Footwear leads by revenue because preventive extra-depth shoes create a replacement opportunity alongside individual offloading purchases. Risk assessment can determine whether buyers need deeper uppers, more width, or a pressure-relieving configuration. Retailers that can fill common sizes quickly are better positioned to convert referrals and retain repeat purchases once a wearer has established a suitable fit.

Distribution Channel

Cross-Border E-Commerce is the fastest-growing route in the model. Oman-facing platforms offer buyers a broader range of sizes and brands than many outlets can carry. The route is especially practical when the customer already knows the model and size. Online economics depend on managing failed deliveries, exchanges, and fit-related returns after allowing for platform fees.

CHAPTER 7 - Regional Analysis

Regional Analysis

Oman ranks fifth by modeled 2025 sales among the five GCC markets compared. Peer estimates use the same product scope and scale Oman's benchmark by diagnosed adult populations, with adjustments for purchasing power, specialist distribution, and adoption. The diagnosis measure indicates screening reach and provides context for addressable demand.

Regional Ranking

5th of 5 peers (2025)

Oman Market Size

USD 10 Mn (2025)

Oman CAGR

8.68% (2025-2032)

Regional Analysis (Current Year)

Regional Analysis Comparison

MetricSaudi ArabiaUnited Arab EmiratesKuwaitQatarOman
Market Size (USD Mn, 2025 / 2032F)112 / 19734 / 6321 / 3611 / 2010 / 17
CAGR (%)8.40% (2025-2032)9.21% (2025-2032)8.00% (2025-2032)8.92% (2025-2032)8.68% (2025-2032)
Adults With Diabetes (000, 2024)5,344.61,274.2908.5409.3412.3
Diagnosed Share of Adults With Diabetes (%, 2024)56.4%36.0%62.7%53.6%50.0%

Market Position

Oman ranks fifth at USD 10 million in 2025. Qatar has a similar adult diabetes population but a higher diagnosed share, which supports a slightly larger modeled footwear market.

Growth Advantage

Oman’s 8.68% CAGR (2025-2032) exceeds Saudi Arabia’s 8.40% (2025-2032) and trails the UAE’s 9.21% (2025-2032). In Oman, adoption grows as specialist fitting reaches more referred patients.

Competitive Strengths

The UAE corridor supplied 51% of Oman’s 2023 leather-upper footwear imports. Muscat adds local foot-pressure assessment, letting suppliers pair consolidated stock sourcing with fitting for patients who need it.

CHAPTER 8 - INDUSTRY ANALYSIS

Growth Drivers, Challenges & Opportunities

Clinical demand, access to fitting, and dependable stocking determine how much of the potential patient population becomes recurring footwear revenue.

Growth Drivers

Diabetic Foot Risk and Repeat Purchases

  • A crude prevalence of 13.2% among adults aged 20-79 (Oman, 2024) supports referral partnerships where clinicians can screen for the subset requiring therapeutic footwear.
  • The 2023 ulcer-prevention guideline recommends footwear with a demonstrated pressure-relieving effect for eligible patients with a healed plantar ulcer. Vendors can compete on documented performance and follow-up.
  • The 2023 offloading guideline separates active-ulcer offloading from routine prevention. Separate purchasing pathways help clinics stock the right products and limit inappropriate substitutions.

Older Patients and Musculoskeletal Demand

  • The reported 4% annual increase in the older population (Oman, 2025) supports investment in fittings for patients who need accessible closures and wider size options.
  • The Omani public orthotic price list (2023) gives suppliers a procurement reference for building separate institutional and cash-pay offers.
  • Local custom foot orthosis services in Muscat show that fitting expertise exists. Footwear suppliers can partner with those practices when the orthosis and shoe are sold as one product.

More Routes to Purchase

  • Oman-facing medical shoe listings let patients reorder known sizes online and give distributors a route to carry less common sizes centrally.
  • Muscat-based foot-pressure assessment gives specialist retailers a service that can convert complex referrals into fitted orders and reduce exchanges.
  • Oman’s orthotic procurement listings give suppliers an institutional route alongside retail. A separate assortment can protect consumer availability during large orders.

Market Challenges

Diagnosis and Referral Gaps

  • The gap between total and diagnosed diabetes cases (Oman, 2024) makes clinic attendance and screening outcomes better stocking inputs than national prevalence alone.
  • The 2023 prevention guideline’s risk categories imply different footwear needs. Broad stocking without clinic-level case information increases the chance of holding slow-moving products.
  • Oman’s Arabic-language diabetic foot education gives clinics material for counseling patients. Retail conversion still depends on directing suitable patients to a fitting they can access.

Import Concentration and SKU Compliance

  • The UAE’s leading position in Oman’s 2023 HS 6403 imports makes consolidated buying efficient, but reliance on one corridor can lengthen stockouts if a wholesaler runs short.
  • The 2025 controlled-products update requires importers to align documentation with the current tariff list. Incomplete SKU files can delay the first shipment and tie up launch capital.
  • Oman provides a medical-device and supplies registration service. Suppliers can stage launch spending once the route for each applicable SKU is confirmed.

Affordability and Uncertain Reimbursement

  • The public orthotic price list (Oman, 2023) provides a tender benchmark. Retailers must account separately for fitting labor, exchanges, and patient service in their prices.
  • Oman-facing marketplace listings expose buyers to a broad price range. Specialist sellers need to explain which features and fitting services justify the total purchase price.
  • The 2023 diabetic ulcer-prevention guideline emphasizes consistent use of recommended footwear in relevant cases. Fit dissatisfaction and replacement cost can undermine repeat sales.

Market Opportunities

Clinic-to-Retail Diabetic Foot Pathways

  • Where foot-pressure assessment is already offered in Muscat, a supplier can sell a fitted footwear package and track its conversion per appointment.
  • Clinics and specialist distributors benefit from a standard referral handoff aligned with the 2023 prevention guideline’s risk assessment approach.
  • Referrals need product and fit criteria that distinguish preventive shoes from the devices indicated under the 2023 active-ulcer offloading guideline.

Pharmacy Stocking for Recovery Footwear

  • Chain buyers can use the 43-branch Avicen network as a reference for pooling slow-moving sizes at a hub and replenishing high-volume outlets.
  • Discharge teams and pharmacies can share fit and pickup information using size ranges like the small and extra-large cast-shoe SKUs listed in Oman.
  • A rollout needs confirmed tariff and documentation handling for each model under the Oman controlled-products update (2025).

Digital Reordering of Fitted Models

Oman-facing therapeutic footwear listings

  • Sellers can offer replacement orders against a saved fitting record. Oman online listings with model-level sizing show how retailers can make the same SKU easy to identify.
  • Specialist outlets can retain the fitting relationship while using domestic pharmacy delivery infrastructure as a reference for lower-cost repeat fulfillment.
  • Online sellers need a way to route changed foot shape or risk back to reassessment, consistent with the 2023 preventive care guidance.

CHAPTER 9 - Competitive Landscape

Competitive Landscape Overview

Specialist importers compete with pharmacy chains and online sellers. Local fitting and ready stock create barriers to entry. The profiles distinguish modeled Oman sales shares from observed product availability.

Market Share Distribution

HUI Medical Supplies (MuscatMed)
Al Farsi Medical Supplies
Noon
Modern Care Medical Equipment Center

Top 5 Players

1
HUI Medical Supplies (MuscatMed)
!$*
2
Al Farsi Medical Supplies
^&
3
Noon
#@
4
Modern Care Medical Equipment Center
$
5
Sky Moon Medical Supplies
&@$
Combined Share$%

Market Dynamics

Local Players70%
Regional/Int'l30%

8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.

Company Profiles (Top 10 Players)
Company Name
Market Share
Headquarters
Founding Year
Core Market Focus
HUI Medical Supplies (MuscatMed)
10.5% (2025 estimate)Muscat, Oman2018Offloading and postoperative shoes, with local fitting.
Al Farsi Medical Supplies
8.4% (2025 estimate)Muscat, Oman2008Orthopedic supply and fitting, with in-scope footwear sales estimated in the sizing brief.
Noon
6.3% (2025 sales through platform, estimated)--Oman-facing marketplace for medical and postoperative shoes.
Modern Care Medical Equipment Center
3.7% (2025 estimate)Seeb, Oman-Medical equipment retail, with therapeutic footwear participation estimated in the sizing brief.
Sky Moon Medical Supplies
0.8% (2025 estimate)Muscat, Oman2004Medical-supply distribution, with footwear participation estimated in the sizing brief.
Avicen Pharmacy
---Local pharmacy channel for rocker-sole cast shoes.
Tynor
---Cast-shoe brand carried by an Oman pharmacy retailer.
OrthoComfoot
---Wide-fit orthopedic and diabetic footwear listed for Oman.
Desertcart
---Cross-border retail listings for diabetic and orthopedic footwear.
Ubuy
---Cross-border listings for wide-fit therapeutic shoes.

Cross Comparison Parameters

The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.

1

Core Size Fill Rate

2

Fit-Related Return Rate

3

Net Footwear Revenue per Pair

4

Gross Margin per Pair

Analysis Covered

Market Share Analysis:

Compares estimated domestic sales shares across profiled distributors and channels.

Cross Comparison Matrix:

Benchmarks inventory availability, fit-related returns, realized revenue, and unit margins.

SWOT Analysis:

Assesses fitting capability, procurement exposure, local reach, and online competition.

Pricing Strategy Analysis:

Compares realized prices after channel discounts, delivery, and return costs.

Company Profiles:

Documents local routes to market, product focus, and available facts.

CHAPTER 10 - REPORT TOC

Table of Contents

86Pages
34Chapters
10Companies Profiled
7Segmentation Types
Phase 1

Market Assessment Phase

11

Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.

Phase 2

Go-To-Market Strategy Phase

15 chapters

Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.

Phase 3

Survey Phase

8 chapters

Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers.

Complete Report Coverage

201+ detailed sections covering every aspect of the market

143

Assessment Sections

58

Strategy Sections

CHAPTER 11 - Our Approach

Research Methodology

Desk Research

  • Review Oman diabetic foot indicators
  • Map footwear imports by heading
  • Audit clinical footwear product listings
  • Compare retail and tender assortments

Primary Research

  • Plan interviews with procurement managers
  • Recruit podiatrists and clinical orthotists
  • Screen footwear category buying teams
  • Target licensed pharmacy purchasing managers

Validation and Triangulation

  • Design validation for 250 respondents
  • Check final sales against shipments
  • Reconcile fit-adjusted selling price assumptions
  • Compare diagnoses with referral volumes

CHAPTER 12 - FAQ

FAQs

Still have questions?

Our research team is here to help you find the right solution

Contact Research Team

CHAPTER 13 - Related Research

Explore Related Reports

Expand your market intelligence with complementary research across regions and adjacent markets.

Regional/Country Reports

Related market analysis across key regions

No regional reports found.

Adjacent Reports

Related markets and complementary research

  • Vietnam Diabetic Foot Care Market
  • Germany Orthopedic Footwear Market
  • South Africa Medical Device Distribution Market
  • KSA Foot Pressure Analysis Technology Market
  • Qatar Custom Orthotics Market

500+

Market Research Reports

50+

Countries Covered

15+

Industry Verticals

Want the full report and an analyst walkthrough?

Unlock the complete dataset, segmentation cuts, and competitive analysis—plus a discovery call that maps insights to your go-to-market priorities.

;Oman Medical Footwear Market Share, Companies & Trends Report 2025-2032